Lori Anne Kunkel, Director: Enliven Therapeutics ELVN Sell · Filed 06/09

Trade details

Type: Insider sale
Amount: $266,664.12
Shares · price: 7,779 sh · $34.28 a share
Held after: 54,105 sh
Stock: Enliven Therapeutics ELVN
Person: Lori Anne KunkelDirector
Trade date: 26/06/05
Filed: 26/06/09
Days to filing: 4 days

Sold 12.6% of holdings

Share of holding sold: 12.6%

Enliven Therapeutics trades, last 26 weeks

What else happened in Enliven Therapeutics around then

Filed or reported within 30 days of the trade day · 05/06~07/05

Lori Anne Kunkel's recent trades

Lori Anne KunkelDirector
Sell10b5-1 planEnliven Therapeutics
Sell10b5-1 plan
Enliven Therapeutics
ELVN
$66K
1,867 sh
$66K
Filed 06/09
Traded 06/05
Lori Anne KunkelDirector
Sell10b5-1 planEnliven Therapeutics
Sell10b5-1 plan
Enliven Therapeutics
ELVN
$12.7K
354 sh
$12.7K
Filed 06/09
Traded 06/05
Lori Anne KunkelDirector
Planned sale10b5-1 planEnliven Therapeutics
Planned sale10b5-1 plan
Enliven Therapeutics
ELVN
$709.8K
20,000 sh
$709.8K
Filed 06/05
Traded 06/05

Lori Anne Kunkel, Director — sold $266.7K of Enliven Therapeutics ELVN · 12.6% of holdings · 10b5-1 plan | Whalegun